{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:45:46Z","timestamp":1780469146412,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Neuroradiol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00062-014-0289-3","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T06:51:34Z","timestamp":1390891894000},"page":"143-150","source":"Crossref","is-referenced-by-count":65,"title":["Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification"],"prefix":"10.1007","volume":"25","author":[{"given":"A.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M. P.","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"289_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/neuonc\/noq143","volume":"13","author":"E Essock-Burns","year":"2011","unstructured":"Essock-Burns E, Lupo JM, Cha S, et al. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2011;13:119\u201331.","journal-title":"Neuro Oncol"},{"key":"289_CR2","first-page":"1989","volume":"24","author":"M Law","year":"2003","unstructured":"Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989\u201398.","journal-title":"Am J Neuroradiol"},{"key":"289_CR3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/neuonc\/nos128","volume":"14","author":"RF Barajas Jr","year":"2012","unstructured":"Barajas RF Jr, Phillips JJ, Parvataneni R, et al. Regional variation in histopathologic features of tumor specimens from treatmentnaive glioblastoma correlates with anatomic and physiologic MR imaging. Neuro Oncol. 2012;14:942\u201354.","journal-title":"Neuro Oncol"},{"key":"289_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","volume":"37","author":"RJ Young","year":"2013","unstructured":"Young RJ, Gupta A, Shah AD, et al. MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clin Imaging. 2013;37:41\u20139.","journal-title":"Clin Imaging"},{"key":"289_CR5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2532090007","volume":"253","author":"RF Barajas Jr","year":"2009","unstructured":"Barajas RF Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009;253:486\u201396.","journal-title":"Radiology"},{"key":"289_CR6","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.0b013e31821d74e7","volume":"76","author":"RJ Young","year":"2011","unstructured":"Young RJ, Gupta A, Shah AD, et al. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology. 2011;76:1918\u201324.","journal-title":"Neurology"},{"key":"289_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"289_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bjc.6606031","volume":"104","author":"M Vitucci","year":"2011","unstructured":"Vitucci M, Hayes DN, Miller CR. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy. Br J Cancer. 2011;104:545\u201353.","journal-title":"Br J Cancer"},{"key":"289_CR9","doi-asserted-by":"crossref","unstructured":"Jain R, Poisson L, Narang J, et al. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology. 2013 Apr;267(1):212\u201320. doi: 10.1148\/radiol.12120846. Epub 2012 Dec 13.","DOI":"10.1148\/radiol.12120846"},{"key":"289_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3174\/ajnr.A2956","volume":"33","author":"R Jain","year":"2012","unstructured":"Jain R, Poisson L, Narang J, et al. Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study. AJNR Am J Neuroradiol. 2012;33:1343\u20138.","journal-title":"Am J Neuroradiol"},{"key":"289_CR11","doi-asserted-by":"crossref","unstructured":"Huang PH, Xu AM, White FM. Oncogenic EGFR signaling networks in glioma. Sci Signal. 2009;2:re6.","DOI":"10.1126\/scisignal.287re6"},{"key":"289_CR12","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa051918","volume":"353","author":"IK Mellinghoff","year":"2005","unstructured":"Mellinghoff IK, Wang MY, Vivanco I, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med. 2005;353:2012\u201324.","journal-title":"N Engl J Med"},{"key":"289_CR13","first-page":"3335","volume":"62","author":"A Lal","year":"2002","unstructured":"Lal A, Glazer CA, Martinson HM, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res. 2002;62:3335\u20139.","journal-title":"Cancer Res"},{"key":"289_CR14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jocn.2008.12.005","volume":"16","author":"HK Gan","year":"2009","unstructured":"Gan HK, Kaye AH, Luwor RB. The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci. 2009;16:748\u201354.","journal-title":"J Clin Neurosci"},{"key":"289_CR15","doi-asserted-by":"crossref","unstructured":"Liu L, Backlund LM, Nilsson BR, et al. Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas. J Mol Med (Berl). 2005;83:917\u201326.","DOI":"10.1007\/s00109-005-0700-2"},{"key":"289_CR16","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2006.08.0705","volume":"25","author":"CE Pelloski","year":"2007","unstructured":"Pelloski CE, Ballman KV, Furth AF, et al. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol. 2007;25:2288\u201394.","journal-title":"J Clin Oncol"},{"key":"289_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijrobp.2010.01.070","volume":"80","author":"JH Uhm","year":"2011","unstructured":"Uhm JH, Ballman KV, Wu W, et al. Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo\/North central cancer treatment group study N0074. Int J Radiat Oncol Biol Phys. 2011;80:347\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"289_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-009-0067-2","volume":"98","author":"DM Peereboom","year":"2010","unstructured":"Peereboom DM, Shepard DR, Ahluwalia MS, et al. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol. 2010;98:93\u20139.","journal-title":"J Neurooncol"},{"key":"289_CR19","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2010.28.6963","volume":"28","author":"JH Sampson","year":"2010","unstructured":"Sampson JH, Heimberger AB, Archer GE, et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol. 2010;28:4722\u20139.","journal-title":"J Clin Oncol"},{"key":"289_CR20","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1073\/pnas.0801279105","volume":"105","author":"M Diehn","year":"2008","unstructured":"Diehn M, Nardini C, Wang DS, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A. 2008;105:5213\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"289_CR21","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1158\/1078-0432.CCR-05-0713","volume":"11","author":"M Aghi","year":"2005","unstructured":"Aghi M, Gaviani P, Henson JW, et al. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Clin Cancer Res. 2005;11:8600\u20135.","journal-title":"Clin Cancer Res"},{"key":"289_CR22","doi-asserted-by":"crossref","unstructured":"Young RJ, Gupta A, Shah AD, et al. Potential role of preoperative conventional MRI including diffusion measurements in assessing EGFR gene amplification status in glioblastoma patients. AJNR Am J Neuroradiol. 2013. Accepted, in press.","DOI":"10.3174\/ajnr.A3604"},{"key":"289_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/neuonc\/nos073","volume":"14","author":"ES Tykocinski","year":"2012","unstructured":"Tykocinski ES, Grant RA, Kapoor GS, et al. Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma. Neuro Oncol. 2012;14:613\u201323.","journal-title":"Neuro Oncol"},{"key":"289_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1091\/mbc.4.1.121","volume":"4","author":"CK Goldman","year":"1993","unstructured":"Goldman CK, Kim J, Wong WL, et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol Biol Cell. 1993;4:121\u201333.","journal-title":"Mol Biol Cell"},{"key":"289_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiol.2231010594","volume":"223","author":"S Cha","year":"2002","unstructured":"Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11\u201329.","journal-title":"Radiology"},{"key":"289_CR26","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1118\/1.3658570","volume":"38","author":"V Patil","year":"2011","unstructured":"Patil V, Johnson G. An improved model for describing the contrast bolus in perfusion MRI. Med Phys. 2011;38:6380\u20133.","journal-title":"Med Phys"},{"key":"289_CR27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3174\/ajnr.A2286","volume":"32","author":"DS Kong","year":"2011","unstructured":"Kong DS, Kim ST, Kim EH, et al. Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status. AJNR Am J Neuroradiol. 2011;32:382\u20137.","journal-title":"Am J Neuroradiol"},{"key":"289_CR28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3174\/ajnr.A2441","volume":"32","author":"R Mangla","year":"2011","unstructured":"Mangla R, Kolar B, Zhu T, et al. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol. 2011;32:1004\u201310.","journal-title":"Am J Neuroradiol"},{"key":"289_CR29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A1362","volume":"30","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Sneed PK, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2009;30:367\u201372.","journal-title":"Am J Neuroradiol"},{"key":"289_CR30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1593\/neo.10688","volume":"12","author":"KJ Hatanpaa","year":"2010","unstructured":"Hatanpaa KJ, Burma S, Zhao D, et al. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia. 2010;12:675\u201384.","journal-title":"Neoplasia"},{"key":"289_CR31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mrm.10446","volume":"49","author":"S Cha","year":"2003","unstructured":"Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003;49:848\u201355.","journal-title":"Magn Reson Med"},{"key":"289_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3174\/ajnr.A2312","volume":"32","author":"SJ Price","year":"2011","unstructured":"Price SJ, Green HA, Dean AF, et al. Correlation of MR relative cerebral blood volume measurements with cellular density and proliferation in high-grade gliomas: an image-guided biopsy study. AJNR Am J Neuroradiol. 2011;32:501\u20136.","journal-title":"Am J Neuroradiol"},{"key":"289_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1522-2586(200002)11:2<114::AID-JMRI6>3.0.CO;2-S","volume":"11","author":"S Cha","year":"2000","unstructured":"Cha S, Lu S, Johnson G, et al. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging. 2000;11:114\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"289_CR34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/PAS.0b013e3182518e12","volume":"36","author":"J Hobbs","year":"2012","unstructured":"Hobbs J, Nikiforova MN, Fardo DW, et al. Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas. Am J Surg Pathol. 2012;36:1186\u201393.","journal-title":"Am J Surg Pathol"},{"key":"289_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1586\/erv.11.177","volume":"11","author":"CA Del Vecchio","year":"2012","unstructured":"Del Vecchio CA, Li G, Wong AJ. Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. Expert Rev Vaccines. 2012;11:133\u201344.","journal-title":"Expert Rev Vaccines"},{"key":"289_CR36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0b013e32834cbb17","volume":"24","author":"G Finocchiaro","year":"2011","unstructured":"Finocchiaro G, Pellegatta S. Immunotherapy for glioma: getting closer to the clinical arena? Curr Opin Neurol. 2011;24:641\u20137.","journal-title":"Curr Opin Neurol"},{"key":"289_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98\u2013110.","journal-title":"Cancer Cell"},{"key":"289_CR38","doi-asserted-by":"crossref","unstructured":"Toh CH, Wei KC, Chang CN, et al. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol. 2013 Jun\u2013Jul;34(6):1145\u20139. doi: 10.3174\/ajnr.A3383. Epub 2013 Jan 24.","DOI":"10.3174\/ajnr.A3383"}],"container-title":["Clinical Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-014-0289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00062-014-0289-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-014-0289-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:23:05Z","timestamp":1558563785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00062-014-0289-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s00062-014-0289-3","relation":{},"ISSN":["1869-1439","1869-1447"],"issn-type":[{"value":"1869-1439","type":"print"},{"value":"1869-1447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}